Insight Molecular Diagnostics (IMDX) Free Cash Flow (2017 - 2026)
Insight Molecular Diagnostics (IMDX) free cash flow from Jun 30, 2017 to Mar 31, 2026. The TTM Insight Molecular Diagnostics (IMDX) free cash flow is -$27M. You can adjust inflation or export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Annual Free Cash Flow
Quarterly Free Cash Flow
Insight Molecular Diagnostics (IMDX) Free Cash Flow CAGR table
| Period | CAGR |
|---|---|
| 1 Year TTM | +16.61% |
| 3 Years TTM | -15.03% |
| 5 Years TTM | -2.40% |
| All Time TTM | +13.57% |
Annual Free Cash Flow change of Insight Molecular Diagnostics (IMDX)
| Year | Free Cash Flow | Change |
|---|---|---|
| 2026 | -$8.25M | -67.48% |
| 2025 | -$25M | +19.50% |
| 2024 | -$21M | -10.04% |
| 2023 | -$24M | -52.71% |
| 2022 | -$50M | +30.69% |
| 2021 | -$38M | +40.35% |
| 2020 | -$27M | +31.90% |
| 2019 | -$21M | +76.63% |
| 2018 | -$12M | -13.29% |
| 2017 | -$13M | N/A |
Comparison Insight Molecular Diagnostics (IMDX) five years free cash flow CAGR with competitors
Insight Molecular Diagnostics (IMDX) five years free cash flow CAGR is -2.39%.
| Ticker | Name | five years Free Cash Flow CAGR | Upside |
|---|---|---|---|
| CDNA | Caredx Inc | 83.64% | -3605.15% |
| CRL | Charles River Laboratories International Inc | 42.96% | -1900.55% |
| EXAS | Exact Sciences Corp | 37.68% | -1678.89% |
| CSTL | Castle Biosciences Inc | 24.94% | -1145.18% |
| MEDP | Medpace Holdings Inc | 24.83% | -1140.61% |
| PSNL | Personalis Inc | 11.39% | -577.31% |
| ICLR | Icon Plc | 10.77% | -551.17% |
| GH | Guardant Health Inc | 10.63% | -545.42% |
| IDXX | Idexx Laboratories Inc | 10.21% | -527.68% |
| RDNT | Radnet Inc | 8.77% | -467.40% |
| QGEN | Qiagen NV | 6.88% | -388.27% |
| MTD | Mettler-Toledo International Inc | 1.98% | -182.87% |
| IQV | IQVIA Holdings Inc | 0.31% | -112.83% |